|
|
Anthony F Lehman
M.D., M.S.P.H.
|
| Academic Title:
Professor |
| Primary Appointment:
Psychiatry |
| Administrative Title:
Chair |
|
alehman@psych.umaryland.edu |
| Location:
110 S Paca,
4N140 |
| Phone:
(410) 328-6735 |
| Fax:
(410) 328-3693 |
|
Personal History
Anthony F. Lehman, MD, MSPH, is Professor and Chair of the Department of Psychiatry at the University of Maryland School of Medicine. He received a B.S. (major-biology) summa cum laude at St. Lawrence University in 1970 and then obtained his MD at the University of Rochester in 1975. Following an internship at the University of Virginia, he completed his residency training in psychiatry at the University of California, Los Angeles. While at UCLA he became a Robert Wood Johnson Clinical Scholar and completed his MSPH at the UCLA School of Public Health in 1981. From 1981-1986 Dr. Lehman directed the Long-Term Care Program at the University of Rochester, an innovative treatment program for young adults with severe mental illnesses. He moved to the University of Maryland in 1986 and directed the Center for Mental Health Services Research there until 2002. He then became Acting and then Interim Chair of the Department of Psychiatry from 1998-2000, before being appointed Chair in October 2000. Recently he chaired the American Psychiatric Association’s Workgroup that updated the APA Guidelines on Treatment of Schizophrenia. He is the recipient of numerous awards, including the American Psychiatric Association Senior Award for Research Development in Psychiatric Services Research, the Distinguished Service Award from the National Alliance for the Mentally Ill, the Robert Cancro Best Chair Award from the American Academy of Child and Adolescent Psychiatry, the APA Alexander Gralnick Award for Research in Schizophrenia, and the Armin Loeb Award for Research from the International Association for Psychosocial Rehabilitation Services.
Research Interests
Dr. Lehman is a nationally renowned mental health services researcher. Much of his research has examined outcomes of persons with severe and persistent mental illnesses, in particular assessing quality of life. He has also studied the impacts of substance use disorders among person with mental illnesses on diagnosis and outcomes, the effectiveness of assertive community treatment programs for homeless persons with severe mental disorders, and the effectiveness of interventions for families. His most recent research examined the quality of care provided to persons with schizophrenia. He has written over 150 scientific articles and is co-author of two books, Working with Families of the Mentally Ill and Double Jeopardy: Chronic Mental Illness and Substance Use Disorders. He was Principal Investigator for the Schizophrenia Patient Outcomes Research Team, funded by the Agency for Health Care Policy and Research and the National Institute of Mental Health. He was also Principal Investigator on the Maryland Employment Demonstration Project for Persons with Psychiatric Disabilities, funded by the Center for Mental Health Services, and Co-Principal Investigator on the NIMH-funded Center for Research on Services for Severe Mental Illnesses and the Maryland Medicaid Patterns of Care and Outcomes Study, also funded by NIMH.
Clinical Speciality
Director and Clinical Chief specializing in Schizophrenia; Major Affective Disorders.
Publications
Lehman AF, Ward NC, Linn LS: Chronic mental patients: the quality of life issue. American Journal of Psychiatry, 1982, 139:1271-1276.
Lehman AF, Strauss JS, Ritzler BA, Kokes RF, Harder DW, Gift TE: First admission psychiatric ward milieu: treatment process and outcome. Archives of General Psychiatry, 1982, 39:1293-1298.
Lehman AF: The well-being of chronic mental patients: assessing their quality of life. Archives of General Psychiatry, 1983, 40:369-373.
Lehman, AF, Linn LS: Crimes against discharged mental patients in board and care homes. American Journal of Psychiatry, 1984, 141:271-274.
Lehman, AF, Babigian HM, Reed SK: The epidemiology of treatment for chronic and non-chronic mental disorders. Journal of Nervous and Mental Disease, 1984, 172:658-666
Lehman AF: Capitation payment and mental health care: a review of the opportunities and risks. Hospital and Community Psychiatry, 1987, 38:31-38.
Lehman AF: A quality of life interview for the chronically mentally ill. Evaluation and Program Planning, 1988, 11:51-62.
Goldman HH, Lehman AF, Morrissey JP, Newman SJ, Frank RG, Steinwachs DM: Design for the national evaluation of the Robert Wood Johnson Foundation Program on Chronic Mental Illness. Hospital and Community Psychiatry, 1990, 41:1217-1221.
Zastowny TR, Lehman AF, Cole RE, Kane C: Family management of schizophrenia: a comparison of behavioral and supportive family treatment. Psychiatric Quarterly, 1992, 63:159-186.
Attkisson C, Cook J, Karno M, Lehman A, McGlashan TH, Meltzer HY, O'Connor M, Richardson D, Rosenblatt A, Wells K, Williams J: Clinical services research. Schizophrenia Bulletin, 1992, 18:561-626.
Lehman AF, Herron JD, Schwartz, RP: Rehabilitation for young adults with severe mental illness and substance abuse disorders: a clinical trial. Journal Nervous and Mental Disease, 1993, 181:88-92.
Lehman, AF, Myers, CP, Thompson JW, Corty, E: Implications of mental and substance use disorders: a comparison of "single" and "dual" diagnosis patients. Journal of Nervous and Mental Disease, 1993, 181:365-370.
Lehman AF, Postrado LT, Roth D, McNary SW, Goldman, HH: An evaluation of continuity of care, case management, and client outcomes in the Robert Wood Johnson Program on Chronic Mental Illness, The Milbank Quarterly, 1994, 72:105-122.
Lehman AF, Myers CP, Corty E, Thompson J: Severity of substance use disorders among psychiatric inpatients. Journal of Nervous and Mental Disease, 1994, 182:164-167.
Lehman AF, Thompson JT, Dixon LB, Scott JC: Treatment outcomes research in schizophrenia: translating research into practice. Schizophrenia Bulletin, 1995, 21:561-566.
Lehman AF: Measuring quality of life in a reformed health system. Health Affairs, 1995, 14:90-101.
Lehman AF, Dixon LB, Kernan E, DeForge BR, Postrado LT. A randomized trial of assertive community treatment for homeless persons with severe mental illness. Archives of General Psychiatry, 1997, 54:1038-1043.
Dixon LB, Weiden P, Torres M, Lehman A. Assertive community treatment and medication compliance in the homeless mentally ill. American Journal of Psychiatry, 1997, 154:1302-1304.
Lehman AF, Steinwachs DS, and PORT investigators. At Issue: Translating research into practice: the Schizophrenia PORT Treatment Recommendations. Schizophrenia Bulletin, 1998, 24:1-10.
Lehman AF, Steinwachs DS, and PORT investigators. Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team client survey. Schizophrenia Bulletin, 1998, 24:1-11-20.
Lehman AF. Public health policy, community services, and outcomes for patients with schizophrenia. Psychiatric Clinics of North America, 1998, 21:221-231.
Lehman AF, Dixon LD, Hoch JS, DeForge B, Kernan E, Frank R: Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness. British Journal of Psychiatry, 1999, 174:346-352.
Lehman AF: Quality care for persons with schizophrenia. Health Affairs, 1999, 18:52-65.
Lehman AF, Goldberg, R, Dixon LB, McNary S, Postrado L, Hackman A, McDonnell K: Improving employment outcomes for persons with severe mental illnesses. Arch Gen Psychiatry, 2002, 59:165-172.
Goldberg RW, Seybolt DC, Lehman AF: Reliable self-report of health service use by individuals with severe mental illness. Psychiatric Services, 2002, 53:879-881.
Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF: Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry, 2002, 159(8):1395-1402.
Buchanan RW, Kreyenbuhl J, Zito JM, Lehman A: The schizophrenia PORT pharmacological treatment recommendations: Conformance and implications for symptoms and functional outcome. Schizophrenia Bulletin, 2002, 28(1):63-73.
Dausey DJ, Rosenheck RA, Lehman AF: Preadmission care as a new mental health performance indicator. Psychiatric Services, 2002, 53(11):1451-1455.
DosReis S, Zito, Buchanan R, Lehman AF: Antipsychotic dosing and concurrent psychotropic treatments for medicaid-insured individuals with schizophrenia, 2nd version, Schizophrenia Bulletin, 2003, 28 (4):607-61.
Lehman AF, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden L, Kreyenbuhl J: Evidence-based treatment of schizophrenia. Psychiatr Clin N Am, 2003, 26:939-954.
Twamley EW, Jeste DV, Lehman AF: Vocational Rehabilitation in Schizophrenia and Other Psychotic Disorders: A Literature Review and Meta-Analysis of Randomized Controlled Trials. Journal of Nervous and Mental Disease, 2003, 191(8):515-523.
Lehman AF and Steinwachs DM: Evidence-based Psychosocial Treatment Practices in Schizophrenia: Lessons from the Patient Outcomes Research Team (PORT) Project. J Amer Acad of Psychoanalysis, 2003, 31(1):141-154.
Lehman AF, Fischer EP, Postrado L, Delahanty J, Johnstone BM, Russo PA, Crown WH: The schizophrenia care and assessment project health questionnaire (SCAP-HQ): An instrument to assess outcomes of schizophrenia care. Schizophrenia Bulletin, 2003, 29(2):247-256.
Kreyenbuhl J, Zito JM, Buchanan RW, Soeken KL, Lehman AF: Racial disparity in the pharmacological management of schizophrenia. Schizophrenia Bulletin, 29(2):183-193, 2003.
Daumit GL, Clark JM, Steinwachs DM, Graham CM, Lehman A, Ford DE: Prevalence and Correlates of Obesity in a Community Sample of Individuals with Severe and Persistent Mental Illness. Journal of Nervous and Mental Disease, 191(12):799-805, 2003.
Frank RG, Berndt ER, Busch AB, Lehman AF: Quality-constant price indexes for the ongoing treatment of schizophrenia: An exploratory study. Special Issue of the Quarterly Review of Economics and Finance, National Bureau of Economic Research, Inc., 22:390-409, 2004.
Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J: Practice Guideline for the Treatment of Patients with Schizophrenia, 2nd Edition. American Journal of Psychiatry, Supplement, 161(2):1-56, Supplement, 2004.
Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, et al: The schizophrenia patient outcomes research team (PORT): Updated treatment recommendations 2003, Schizophrenia Bulletin, 30(2):193-217, 2004.
Busch A, Frank RG, Lehman AF: The effect of a managed behavioral health care carve-out on quality of care for medicaid patients diagnosed with schizophrenia. Archives of General Psychiatry, 61:442-448, 2004.
Resnick SG, Rosenheck RA & Lehman AF: An exploratory analysis of correlates of recovery. Psychiatric Services, 55:540-547, 2004.
Lehman AF, Goldman HH, Dixon LB, Churchill R: Evidence-based mental health treatments and services: Examples to inform public policy. Milbank Memorial Fund, 1-32, 2004.
Mohr PE, Cheng CM, Claxton K, Conley RR, Feldman Jacob JJ, Hargreaves WA, Lehman AF, et al: The Heterogeneity of Schizophrenia in Disease States. Schizophrenia Research, Nov 1;71(1):83-95, 2004.
Resnick SG, Rosenheck RA, Dixon L, Lehman AF. Correlates of family contact with the mental health system: Allocation of a scarce resource. Mental Health Services Research, 7(2):113-121, 2005.
Resnick SG, Fontana A, Lehman AF, Rosenheck RA: An empirical conceptualization of the recovery orientation. Schizophrenia Research, 75:119-128, 2005.
Cook JA, Lehman AF, Drake R, McFarlane WR, et al: Integration of psychiatric and vocational Services: A multisite randomized, controlled trial of supported employment. American Journal of Psychiatry, 162:1948-1956, 2005.
Razzano LA, Cook JA, Burke-Miller JK, Mueser KT, Pickett-Schenk SA, Grey DD, Goldberg RW, Blyler CR, Gold PB, Leff HS, Lehman AF, et al: Clinical Factors Associated with Employment Among People with Severe Mental Illness: Findings from the Employment Intervention Demonstration Program. Journal of Nervous and Mental Disease, 193:705-713, 2005.
Dickerson FB, and Lehman AF: Evidence-based psychotherapy for schizophrenia. Journal of Nervous and Mental Disease, 194(1):3-9, 2006.
Busch AB, Frank RG, Lehman AF, Greenfield SF: Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-out. Administration and Policy in Mental Health and Health Services Research, published online May 20, 2006, http://dx.doi.org/10.1007/s10488-006-0045-3.
Lehman, AF: Treatment guidelines: Caveat emptor! Journal of Mental Health, 15(2):129-133, April 2006.
Lehman, AF: Promoting recovery: Achieving the promise. Schizophrenia Bulletin, 32(3):430-431, 2006.
Kelly DL, Dixon L, Kreyenbuhl J, Lehman AF, Love RC, Medoff D, Brown C, Conley RR: Clozapine utilization and outcomes by race in a public mental health system: 1994-2000. Journal of Clinical Psychiatry, 67:1404-1411, 2006.
Lehman AF: Editorial. Early intervention for psychosis and schizophrenia. Psychiatry Research, 195(12):965-967, Dec 2007.
DosReis S, Johnson E, Steinwachs D, Rohde C, Skinner EA, Fahey M & Lehman, AF: Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia. Schizophrenia Research, 101:304-311, 2008.
Busch AB, Frank RG, Lehman AF, Goldman HH: Changes over time and disparities in schizophrenia treatment quality, Medical Care, 47(2):199-207, Feb 2009
Faculty members:
Click here to update your contact information and create a profile.
|